These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9620288)

  • 1. Genetic analysis of male pattern baldness and the 5alpha-reductase genes.
    Ellis JA; Stebbing M; Harrap SB
    J Invest Dermatol; 1998 Jun; 110(6):849-53. PubMed ID: 9620288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of genetic polymorphisms of steroid 5alpha-reductase type 1 and 2 genes in Korean men with androgenetic alopecia.
    Ha SJ; Kim JS; Myung JW; Lee HJ; Kim JW
    J Dermatol Sci; 2003 Apr; 31(2):135-41. PubMed ID: 12670724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin gene polymorphism and premature male pattern baldness in the general population.
    Ellis JA; Stebbing M; Harrap SB
    Clin Sci (Lond); 1999 Jun; 96(6):659-62. PubMed ID: 10334972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the androgen receptor gene is associated with male pattern baldness.
    Ellis JA; Stebbing M; Harrap SB
    J Invest Dermatol; 2001 Mar; 116(3):452-5. PubMed ID: 11231320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.
    Goodarzi MO; Shah NA; Antoine HJ; Pall M; Guo X; Azziz R
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4085-91. PubMed ID: 16849416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
    Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
    J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical roles of testosterone and epitestosterone to 5 alpha-reductase as indicators of male-pattern baldness.
    Choi MH; Yoo YS; Chung BC
    J Invest Dermatol; 2001 Jan; 116(1):57-61. PubMed ID: 11168798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.
    Lévesque É; Laverdière I; Lacombe L; Caron P; Rouleau M; Turcotte V; Têtu B; Fradet Y; Guillemette C
    Clin Cancer Res; 2014 Feb; 20(3):576-84. PubMed ID: 24277450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extract of Thujae occidentalis semen inhibited 5alpha-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse.
    Park WS; Lee CH; Lee BG; Chang IS
    J Dermatol Sci; 2003 Apr; 31(2):91-8. PubMed ID: 12670719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.
    Hayes VM; Severi G; Padilla EJ; Morris HA; Tilley WD; Southey MC; English DR; Sutherland RL; Hopper JL; Boyle P; Giles GG
    Int J Cancer; 2007 Feb; 120(4):776-80. PubMed ID: 17136762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genetic variants in the two isoforms of 5α-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome.
    Graupp M; Wehr E; Schweighofer N; Pieber TR; Obermayer-Pietsch B
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):175-9. PubMed ID: 21530059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of polymorphisms in the SRD5A2 gene and semen parameters in Estonian men.
    Peters M; Saare M; Kaart T; Haller-Kikkatalo K; Lend AK; Punab M; Metspalu A; Salumets A
    J Androl; 2010; 31(4):372-8. PubMed ID: 19926884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
    Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
    Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1.
    Ellis JA; Panagiotopoulos S; Akdeniz A; Jerums G; Harrap SB
    J Hum Genet; 2005; 50(10):534-537. PubMed ID: 16155734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient expression of the 5alpha-reductase type 2 isozyme in the rat brain in late fetal and early postnatal life.
    Poletti A; Negri-Cesi P; Rabuffetti M; Colciago A; Celotti F; Martini L
    Endocrinology; 1998 Apr; 139(4):2171-8. PubMed ID: 9529007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
    Ryu HK; Kim KM; Yoo EA; Sim WY; Chung BC
    Br J Dermatol; 2006 Apr; 154(4):730-4. PubMed ID: 16536818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients.
    Maimoun L; Philibert P; Cammas B; Audran F; Bouchard P; Fenichel P; Cartigny M; Pienkowski C; Polak M; Skordis N; Mazen I; Ocal G; Berberoglu M; Reynaud R; Baumann C; Cabrol S; Simon D; Kayemba-Kay's K; De Kerdanet M; Kurtz F; Leheup B; Heinrichs C; Tenoutasse S; Van Vliet G; Grüters A; Eunice M; Ammini AC; Hafez M; Hochberg Z; Einaudi S; Al Mawlawi H; Nuñez CJ; Servant N; Lumbroso S; Paris F; Sultan C
    J Clin Endocrinol Metab; 2011 Feb; 96(2):296-307. PubMed ID: 21147889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
    Dallob AL; Sadick NS; Unger W; Lipert S; Geissler LA; Gregoire SL; Nguyen HH; Moore EC; Tanaka WK
    J Clin Endocrinol Metab; 1994 Sep; 79(3):703-6. PubMed ID: 8077349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minoxidil increases 17 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase activity of cultured human dermal papilla cells from balding scalp.
    Sato T; Tadokoro T; Sonoda T; Asada Y; Itami S; Takayasu S
    J Dermatol Sci; 1999 Feb; 19(2):123-5. PubMed ID: 10098703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.